StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) stock

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3099% above fair value
$167.58−0.50 (-0.30%)

Close on Nov 16, 2026Market cap $207.86BP/E –Yield 1.89%

Gilead Sciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Gilead Sciences's EV/EBITDA was 17.0× on Jul 31, 2026, against 19.1× a year earlier. Over the last 5 years it ranged from 9.3× to 169.4×, with a median of 16.6×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202617.0×+0.8
2025Dec 31, 202516.2×−145.9
2024Dec 31, 2024162.1×+147.7
2023Dec 29, 202314.4×−6.8
2022Dec 30, 202221.2×+11.5
2021Dec 31, 20219.7×−21.5
2020Dec 31, 202031.2×+11.8
2019Dec 31, 201919.4×+10.8
2018Dec 31, 20188.6×+2.6
2017Dec 29, 20176.0×+0.3
2016Dec 30, 20165.7×−1.6
2015Dec 31, 20157.4×−4.7
2014Dec 31, 201412.0×−15.2
2013Dec 31, 201327.2×+10.6
2012Dec 31, 201216.7×+9.0
2011Dec 30, 20117.7×+0.5
2010Dec 31, 20107.2×−4.7
2009Dec 31, 200912.0×–

More Gilead Sciences figures

See a number that looks wrong?